Breaking News
January 20, 2019 - New study takes first step toward treating endometriosis
January 20, 2019 - Researchers find how GREB1 gene promotes resistance to prostate cancer treatments
January 20, 2019 - Replacing Sitting Time With Activity Lowers Mortality Risk
January 20, 2019 - A simple, inexpensive intervention makes birth safer for moms and babies in parts of Africa
January 19, 2019 - New anti-inflammatory compound acts as ‘surge protector’ to reduce cancer growth
January 19, 2019 - Significant flaws found in recently released forensic software
January 19, 2019 - New Leash on Life? Staying Slim Keeps Pooches Happy, Healthy
January 19, 2019 - Men and women remember pain differently
January 19, 2019 - Rising air pollution linked with increased ER visits for breathing problems
January 19, 2019 - Study uses local data to model food consumption patterns among Seattle residents
January 19, 2019 - The brain’s cerebellum plays role in controlling reward and social behaviors, study shows
January 19, 2019 - Relationship between nurse work environment and patient safety
January 19, 2019 - Pioneering surgery restores movement to children paralyzed by acute flaccid myelitis
January 19, 2019 - Genetic variants linked with risk tolerance and risky behaviors
January 19, 2019 - New research provides better understanding of our early human ancestors
January 19, 2019 - First-ever tailored reporting guidance to improve patient care and outcomes
January 19, 2019 - 4.6 percent of Massachusetts residents have opioid use disorder
January 19, 2019 - New study suggests vital exhaustion as risk factor for dementia
January 19, 2019 - New antibiotic discovery heralds breakthrough in the fight against drug-resistant bacteria
January 19, 2019 - Ural Federal University scientists synthesize a group of multi-purpose fluorophores
January 19, 2019 - Researchers identify new therapeutic target in the fight against chronic liver diseases
January 19, 2019 - Preparation, characterization of Soyasapogenol B loaded onto functionalized MWCNTs
January 19, 2019 - FDA Approves Ontruzant (trastuzumab-dttb), a Biosimilar to Herceptin
January 19, 2019 - Tobacco use linked with higher use of opioids and sedatives
January 19, 2019 - Study delves deeper into developmental dyslexia
January 19, 2019 - Anti-vaccination movement one of the top health threats in 2019 says WHO
January 19, 2019 - Newly developed risk score more effective at identifying type 1 diabetes
January 19, 2019 - Highly effective protocol to prepare cannabis samples for THC/CBD analysis
January 19, 2019 - Prinston Pharmaceutical Inc. Issues Voluntary Nationwide Recall of Irbesartan and Irbesartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodiethylamine (NDEA) in the Products
January 19, 2019 - How does solid stress from brain tumors cause neuronal loss, neurologic dysfunction?
January 19, 2019 - $14.7 million partnership to supercharge vaccine development
January 19, 2019 - Ian Fotheringham receives Charles Tennant Memorial Lecture award
January 19, 2019 - Brain vital signs detect neurophysiological impairments in players with concussions
January 19, 2019 - Lack of job and poor housing conditions increased likelihood of people attending A&E
January 19, 2019 - Novel targeted drug delivery system improves conventional cancer treatments
January 19, 2019 - Rutgers study finds gene responsible for spread of prostate cancer
January 19, 2019 - Complications Higher Than Expected for Invasive Lung Tests
January 19, 2019 - 3-D printed implant promotes nerve cell growth to treat spinal cord injury
January 19, 2019 - Automated texts lead to improved outcomes after total knee or hip replacement surgery
January 19, 2019 - Poor cardiorespiratory fitness could increase risk of future heart attack, finds new study
January 19, 2019 - Drinking soft drinks while exercising in hot weather may increase risk of kidney disease
January 19, 2019 - Formlabs 3D prints anatomical models
January 19, 2019 - Heart-Healthy Living Also Wards Off Type 2 Diabetes
January 19, 2019 - Teaching Kids to Be Smart About Social Media (for Parents)
January 19, 2019 - Metabolite produced by gut microbiota from pomegranates reduces inflammatory bowel disease
January 19, 2019 - Researchers examine how spray from showers and toilets expose us to disease causing bacteria
January 19, 2019 - Behavioral experiments confirm that additional neurons improve brain function
January 19, 2019 - New study compares performance of real-time infectious disease forecasting models
January 19, 2019 - Obesity can be risk factor for developing renal cell carcinoma, confirms study
January 19, 2019 - New regulation designs on cigarette packs direct smokers’ attention to health warnings
January 19, 2019 - QIAGEN receives first companion diagnostic approval in Japan
January 19, 2019 - Study explores role of Dunning-Kruger effect in anti-vaccine attitudes
January 19, 2019 - Newly identified subset of immune cells may be key to fighting chronic inflammation
January 19, 2019 - New immune response regulators discovered
January 18, 2019 - Poor blood oxygenation during sleep predicts chance of heart-related death
January 18, 2019 - First international consensus on the diagnosis and management of fibromuscular dysplasia
January 18, 2019 - Rapid resistance gene sequencing technology can hasten identification of antibiotic-resistant bacteria
January 18, 2019 - Researchers develop artificial enzymatic pathway for synthesizing isoprenoids in E. coli
January 18, 2019 - Scientists advise caution in immunotherapy research
January 18, 2019 - How children across the world develop language
January 18, 2019 - Columbia Medical Student Receives McDonogh Scholarship
January 18, 2019 - Secretive ‘Rebate Trap’ Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
January 18, 2019 - Plant based diet could be the best option for the planet says commission
January 18, 2019 - New conservation practice could reduce nitrogen from agricultural drainage, study shows
January 18, 2019 - UIC researchers receive $1.7 million NCI grant to study Southeast Asian fruit
January 18, 2019 - New study determines the fate of DNA derived from genetically modified food
January 18, 2019 - Scientists develop new gene therapy that prevents axon destruction in mice
January 18, 2019 - Study finds critically low HPV vaccination rates among younger adolescents in the U.S.
January 18, 2019 - Brain cells involved in memory play key role in reducing future eating behavior
January 18, 2019 - Risk for Conversion of MS Varies With Different Therapies
January 18, 2019 - Investigational cream may help patients with inflammatory skin disease
January 18, 2019 - Medical school news office receives six writing awards | News Center
January 18, 2019 - County By County, Researchers Link Opioid Deaths To Drugmakers’ Marketing
January 18, 2019 - Research reveals risk for developing more than one mental health disorder
January 18, 2019 - Scientists discover a dramatic pattern of bone growth in female mice
January 18, 2019 - Study finds link between lengthy periods of undisturbed maternal sleep and stillbirths
January 18, 2019 - New nuclear medicine method could improve detection of primary and metastatic melanoma
January 18, 2019 - Combination therapy shows high efficacy in treating people with leishmaniasis and HIV
January 18, 2019 - Health Tip: Don’t Ignore Changes in Skin Color
January 18, 2019 - Dietary Recommendations for Healthy Children
Patient Outcomes of Prostate Cancer with Whole Slide Imaging

Patient Outcomes of Prostate Cancer with Whole Slide Imaging

image_pdfDownload PDFimage_print

An interview with Dr. Anil Parwani, discusses how whole slide imaging of prostate cancer sections is helping to inform pathologists and improve patient outcomes.

Prostate cancer is often a devastating diagnosis for any patient to receive, please give an overview of the factors that contribute to the severity of the condition.

Prostate cancer is one of the most common cancers in men in the Western Hemisphere. It is more common in older men, but occasionally younger patients present with prostate cancer. Even at a younger age, the risk of cancer is not clear; we do not have a good understanding of how it progresses. Cancers that appear to have a similar morphology might behave differently between patients.

In some patients the cancer progresses very quickly, so we need a good risk assessment score to separate out these patients.  When the cancer spreads to the bone and liver, the outcome for patients is poor. In a certain percentage of cases, the cancer is caught at a late stage, which can be devastating for patients.

What research do you and your lab conduct in prostate cancer? What are the end goals?

As a pathologist, my goal is to find good diagnostic assays that can help us stratify patients according to risk. We would like to find a model way of looking at a patient’s cancer and its morphology to see if we can identify anything unique in that patient’s biopsy that can separate them out and be predictive of how they will progress and what their outcome will be. We would then like to be able to offer therapeutic options to the patient based on this.

How do you and your lab approach your research into prostate cancer?

We have been assessing prostate cancer slides from patients for the last seven or eight years. We have been creating an image database of known prostate cancers and how the patients do. We have been looking at this retrospectively to see if we can understand patterns we can apply to the prostate cancer for a better future diagnosis.

Our goal is to find better predictors of outcomes, such as the microenvironment of the cancer, how the cancer is growing in the stroma or what surrounds the prostate cancer cells. We would like to see if there are any unique signatures that we can decipher in this digital image.

Also, within a prostate biopsy, there might be benign mimickers of cancer, which can lead to misdiagnosis of cancer and overtreatment. We would like to find diagnostic features in the digitized slide that will help us separate the benign mimickers from variants of prostate cancer.

At the Digital Pathology Scanning Center, we have scanned over 800,000 slides over the last year and about ten percent of those are prostate cancer slides. We are creating one of the largest databases of prostate cancer tissues and the goal is to use this incredible resource to answer many of these questions.

What are the challenges associated with scaling up the digital pathology to such a large scale?

One challenge is being able to get a glass slide that is produced in the lab and convert that into a digital image. It requires a lot of streamlining and standardization of the processes. People have been scanning slides for many years, but when you start to do it on a large scale in a clinical lab, you have to pay very careful attention to detail and the standardization of the processes.

You have to follow rules and regulations, because these are patient materials. When these materials are digitized, and images are produced, we want to make sure that the image is a replica of the glass slide. We have to validate that process. We have to look at a glass slide diagnosis, compare it to a digital diagnosis and make sure that they are no different.

We also need to have downtime processes to cater for if the system goes down. Being able to function in a clinical setting requires teamwork. Just one or two people in the pathology department could not do it. We have to start working with multiple outside stakeholders, the IT department, the financial department, for example, which requires an incredible effort.

What are the unique challenges to standardizing workflows and scanning large prostate sections?

In our institute, we perform full-mount processing of prostate slides. When a patient has a biopsy, they are processed in the standard way to produce a standard slide. For the full mounts, we take the whole prostate. We ink it, fix it and then then obtain many sections of the whole tissue.

We put those into a large cassette that is processed, and paraffin blocks are made. From those paraffin blocks we make very thin, unstained slides which are then stained with H&E. One of the challenges that is unique to scanning such large slides is the need for special equipment. You need special scanners; not every whole slide imaging scanner can accommodate these large slides.

How has the TissueScope LE 120 affected the digital pathology lab at The James Cancer Hospital? What are the advantages and limitations?

The TissueScope scanner is optimized for whole mount slides, but it can also accommodate standard-sized slides as well. We like it because we are required to place whole mount tissue in special 2 by 3 slides and this scanner enables us to do that.

It enables us to mix and match to use standard slides, full mounts and it is even capable of scanning a slide up to 6 by 8, which is a very unique feature of the system. We can accommodate a large, high-throughput scanning workflow, all whilst maintaining good image quality. It is a very versatile, easy-to-use system that can scan a standard slide in less than a minute.

How important is the reliability of the tissue scanner and the image quality of the samples that are produced?

It is extremely important, you want a system that can be optimized for your workflow, with an image quality that replicates the original sample and one that is reliable in performance and throughput. Image calibration and scanning need to be consistently high quality and you want to know you can walk away without issues.  

The TissueScope, along with the other systems in our lab, allows us to continuously scan slides, without any interruptions. This system also has z-stacking capabilities, which is something other systems do not have.

The image quality is also really good, the images are very sharp, clear and crisp. We are at the stage of assessing image quality and validating this for clinical use now. We are looking at glass slide diagnosis in 60 cases and after a washout period of two weeks, pathologists will make a diagnosis based on the images taken and we will compare that to the original glass slide diagnosis.

What does the future hold for your research?

The key thing for the future is to continue scanning high quality images from patients with prostate and other cancers so we can start interrogating them for specific features such as stromal inflammation and the microenvironment of the tumor.

It is a case of continuing to get the image set more annotated and more curated, as well as continuing to obtain follow-up data on these patients because that is how we are going to build image-based signatures for patient stratification and find diagnostic clues that will distinguish between benign mimickers and variants of cancer.

We need to continue this journey of understanding pathology, patterns and how this applies to the grading, diagnosis and outcome of these patients.

What do you see as the future of digital pathology and how it will affect your work and the work of others in your field?

I think the future of digital pathology is very bright in terms of how far we have come from taking one hour to scan a slide to today, where systems can take less than a minute to scan a slide.  Those slides can then be made available to experts worldwide for a second opinion, for example, and, to researchers for analysis and the development of deep learning algorithms.

It will not be long before more labs start to digitize their slides, and this will become the standard way of making a diagnosis in pathology. In the future there will be no “digital pathology,” – it will just be a standard part of pathology and the pathology lab.

Where can readers find more information?

About Dr. Anil Parwani, M.D., PhD, MBA

Professor of Pathology and Biomedical Informatics
The Ohio State University

Anil Parwani is a Professor of Pathology and Biomedical Informatics at The Ohio State University. He also serves as the Director of Division of Pathology Informatics and Digital Pathology, Department of Pathology. Dr. Parwani has sub-speciality training in Genitourinary Pathology.

His pathology practice is focused in GU and he has research interests in benign mimickers and unusual variants of prostate carcinoma, diagnostic and prognostic markers in GU pathology, and molecular classification of renal cell carcinoma and bladder carcinoma.

Dr. Parwani has expertise in the area of Anatomical Pathology Informatics including design of quality assurance tools, tissue banking informatics, clinical and research data integration and mining, synoptic reporting in anatomical pathology, clinical applications of whole slide imaging, digital imaging, telepathology, image analysis and lab automation and workflow processes such as barcoding and voice recognition.

Dr. Parwani has published extensively and has authored over 300 peer-reviewed articles in major scientific journals as well as numerous book chapters and is also the editor of several books. He currently serves as an editor-in-chief of Journal of Pathology Informatics and Diagnostic Pathology.

Tagged with:

About author

Related Articles